One of the reasons why E-cadherin did not affect the peritoneal recurrence of T3 cases might be that E-cadherin might affect the invasion activity of cancer cells at early T-stage such as T1 and T2, but not advanced T-stage such as T3 and T4. This evidence concerns the gene CDH1 and cancer.